PaceMate Names JR Finkelmeier as Chief Commercial Officer

Former Philips Executive Joins to Accelerate Commercial Strategy and Market Growth

SARASOTA, Fla.–(BUSINESS WIRE)–PaceMate®, a market-leading cardiac remote monitoring and cardiac data management platform, today announced the appointment of JR Finkelmeier as its new Chief Commercial Officer. As Chief Commercial Officer, Finkelmeier will oversee PaceMate’s commercial expansion strategy, focusing on investing in sales, marketing, and customer success initiatives.

Finkelmeier brings over 20 years of experience in healthcare and medical technology—most recently as a Business Leader at Philips, where he led the ECG Solutions Business within the Ambulatory Monitoring and Diagnostics Unit. Before Phillips, he was instrumental in transforming BioTelemetry into a diversified portfolio company ahead of its acquisition by Phillips for $2.8 billion, holding leadership roles spanning product, business, and corporate development.

“JR has demonstrated remarkable success in scaling healthcare and medical technology companies,” said Tripp Higgins, PaceMate CEO. “His track record, vision, and expertise make him the ideal leader to drive the adoption of PaceMate’s cardiac monitoring platform and spearhead our next phase of growth.”

“PaceMate is a leader in cardiac care with its advanced cardiac data platform and clinical service capabilities,” said Finkelmeier. “I’m thrilled to join this dedicated team and accelerate our commercial momentum to expand our impact on cardiac patient lives.”

PaceMate provides expansive cardiac software and clinical service capabilities through PaceMateLIVE™, an end-to-end solution that merges the entire cardiac monitoring workflow from ordering through billing. This platform is supported by advanced algorithms and automatic processing—producing efficiencies across clinical, operational, and financial outcomes.

The news comes on the heels of PaceMate’s recent milestone of completing its 100,000th ambulatory patient transmission.

About PaceMate:

PaceMate is a pioneering force in remote cardiac data management. We’re driven by a mission to modernize digital healthcare and envision a future of connected personalized cardiac care. Since 2015, PaceMate has been simplifying and streamlining device clinic operations into one easy-to-use platform—PaceMateLIVE. As the industry’s only comprehensive cardiac remote monitoring solution, PaceMateLIVE uniquely pairs device and EHR data and prioritizes patient care intelligently. Join us at PaceMate.com to see how together—we never miss a beat.®

Contacts

Haley Chute

haley.chute@pacemate.com

Staff

Recent Posts

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

20 minutes ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

20 minutes ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

20 minutes ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

20 minutes ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

20 minutes ago

PulseAI Secures Seed Funding to Advance AI-Driven ECG Diagnostics

BELFAST, Northern Ireland  , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in…

20 minutes ago